Filing summary
IceCure Medical Ltd. furnished this Form 6-K on October 5, 2026, reporting corporate and shareholder-meeting updates. The filing contains no operating or financial results.
Board and shareholder meeting
- Director Yang Huang notified the Company on October 4 that he will not seek re-election. The filing states his decision is not related to any disagreement with the Company’s operations, policies, or practices.
- Mr. Huang will remain a director until the Annual and Special General Meeting on November 2, 2026.
- The Company amended the meeting notice, proxy statement, and proxy card to remove agenda items related to Mr. Huang. These materials supersede the versions furnished on September 28, 2026.
- Shareholders holding ordinary shares at the close of business on October 5, 2026, are entitled to notice of and to vote at the meeting and any postponement or adjournment.
Financial information and outlook
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, guidance, or other financial metrics, and no financial outlook or commentary.
Investor items to verify
- Review Exhibits 99.1–99.3 for the updated meeting agenda, proposals, and voting instructions; their substantive contents are not included in the supplied filing text.
- Confirm the final meeting outcome and any subsequent board changes.
- Note that the 6-K is incorporated by reference into the Company’s specified Form F-3 and Form S-8 registration statements, to the extent not superseded by later filings or furnished reports.